BVF Inc’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,944
| Closed | -$552K | – | 57 |
|
|
2018
Q4 | $552K | Sell |
3,944
-145
| -4% | -$22K | 0.07% | 54 |
|
|
2018
Q3 | $699K | Hold |
4,089
| – | – | 0.06% | 56 |
|
|
2018
Q2 | $709K | Sell |
4,089
-297
| -7% | -$44.6K | 0.07% | 50 |
|
|
2018
Q1 | $506K | Hold |
4,386
| – | – | 0.05% | 42 |
|
|
2017
Q4 | $369K | Sell |
4,386
-234,000
| -98% | -$19.5M | 0.04% | 43 |
|
|
2017
Q3 | $22M | Sell |
238,386
-225,000
| -49% | -$17.5M | 2.79% | 12 |
|
|
2017
Q2 | $37.2M | Buy |
463,386
+143,386
| +45% | +$7.94M | 5.77% | 5 |
|
|
2017
Q1 | $13.5M | Buy |
+320,000
| New | +$13.2M | 2.29% | 15 |
|
|
2016
Q2 | – | Sell |
-74,870
| Closed | -$2.05M | – | 36 |
|
|
2016
Q1 | $2.05M | Sell |
74,870
-636,197
| -89% | -$13.3M | 0.51% | 24 |
|
|
2015
Q4 | $20.2M | Sell |
711,067
-820,041
| -54% | -$22M | 3.45% | 13 |
|
|
2015
Q3 | $26.8M | Sell |
1,531,108
-83,973
| -5% | -$1.64M | 5.41% | 8 |
|
|
2015
Q2 | $29.1M | Buy |
1,615,081
+489,416
| +43% | +$6.69M | 5.14% | 8 |
|
|
2015
Q1 | $14M | Sell |
1,125,665
-65,037
| -5% | -$810K | 2.93% | 14 |
|
|
2014
Q4 | $14M | Sell |
1,190,702
-1,500
| -0.1% | -$17.5K | 2.72% | 13 |
|
|
2014
Q3 | $15.7M | Buy |
+1,192,202
| New | +$15.5M | 3.25% | 10 |
|
Other funds holding LOXO
BVF Inc's LOXO Position: Q1 2019 in Review
BVF Inc sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 3,944 shares — an estimated $552K sold.
BVF Inc first reported a position in LOXO in Q3 2014 and held it in 15 quarters. The position peaked at $37.2M in Q2 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- BVF Inc reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- BVF Inc sold 3,944 Loxo Oncology, Inc shares in Q1 2019, an estimated $552K.
- BVF Inc first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 15 quarters.
- BVF Inc's Loxo Oncology, Inc position peaked at $37.2M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on BVF Inc's 13F filing for Q1 2019, filed 15 May 2019.